Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
about
Predictors of tetanus-diphtheria- acellular pertussis vaccination among adults receiving tetanus vaccine in the United States: data from the 2008 national health interview survey.The variegate neurological manifestations of varicella zoster virus infection.Varicella-zosterImpact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization.Update in geriatric medicine.The global epidemiology of herpes zoster.Herpes zoster: diagnostic, therapeutic, and preventive approaches.Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.Highlights of historical events leading to national surveillance of vaccination coverage in the United States.Review: The neurobiology of varicella zoster virus infection.Comparing Resident Self-Report to Chart Audits for Quality Improvement Projects: Accurate Reflection or Cherry-Picking?Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies.Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study.A systematic review of the cost effectiveness of herpes zoster vaccination.Shingles (herpes zoster) vaccine (zostavax(®)): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged ≥50 years.Varicella zoster: an update on current treatment options and future perspectives.Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster.Factors Related to Pertussis and Tetanus Vaccination Status Among Foreign-Born Adults Living in the United States.Impact of health insurance status on vaccination coverage among adult populations.Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection.Improving adherence to national recommendations for zoster vaccination through simple interventions.Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study.Increased incidence of herpes zoster among patients with systemic lupus erythematosus.
P2860
Q30651557-35128313-8900-46FA-84DC-7F925D2CAD0DQ33732991-3344D53B-4976-47C9-B50F-A75F24264F40Q33848049-A62919B4-22D7-4894-BAC4-BC86E6EEE12EQ33922949-DB982A72-0000-4E56-8C0B-D9EA4BCBF76DQ34061798-DEE3B6E7-324B-4C3D-A66F-3E86EC8B359CQ34368269-0DA621CB-27C1-4B81-9B17-9046C033A0B5Q34376752-F76B5FCC-F80C-4C55-B753-6B707E769ADFQ34683751-315B8FCF-443B-49DC-A737-DD957DF44776Q35040440-D4A1536A-B192-4613-8010-57B80F5DCBE8Q35223289-4CDF1806-4984-4803-ADC5-D1A9CB204492Q35770346-3AA10D06-0882-4D99-98BB-B96882CA1A92Q36829183-E4A1B525-E2F3-4F46-BFEB-06DF0F872ED1Q37355896-75618E6D-3FD4-454A-A4B3-5ABBAACAF586Q38075493-46033757-2EA7-4E68-8099-343FCECFA1C1Q38120494-3E49047C-1B79-47B7-9CE1-0688A75ADBA5Q38167380-A0B4E543-2684-4E06-BEF2-2D2AC0DEC21AQ38837769-7C0A6C26-BF2D-4078-A42D-A5A7A4D63006Q39193433-F2BBFEC4-7D43-40C8-970E-269E803BB7ADQ41044534-61DD3AE4-7C67-4ED3-8B9A-40E0177E5B26Q42366475-60BEAC47-09E1-43C4-89A7-997A2E560F5DQ43727753-9EF97C43-383C-4FFA-9B4C-CCD829D97677Q46086110-35A42B19-F383-4F42-9C00-8F6356E792F4Q51201512-5D3B7715-75E6-44F7-88C6-205354F26AFE
P2860
Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
@en
Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
@nl
type
label
Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
@en
Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
@nl
prefLabel
Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
@en
Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
@nl
P2093
P1476
Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
@en
P2093
Gary L Euler
Peng-jun Lu
Rafael Harpaz
P356
10.1016/J.AMEPRE.2010.10.012
P577
2011-02-01T00:00:00Z